Literature DB >> 18591278

Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.

Sandrine Marchand1, Denis Frasca, Claire Dahyot-Fizelier, Céline Breheret, Olivier Mimoz, William Couet.   

Abstract

Lung microdialysis has been used with rats to investigate antibiotic distribution after single-dose administration. However, conducting such experiments after intravenous infusion at steady state would constitute a more convenient alternative, which was evaluated here, using levofloxacin (LVX) as a test compound. Microdialysis probes were inserted in blood and muscle, used as a comparator, between 9:00 a.m. and 11:00 a.m. Intravenous LVX infusion was started 6 h later and maintained until the end of the experiment at a rate of 1.0 mg.h(-1). Lung microdialysis probes were inserted on the morning of the next day. Rats were kept anesthetized during dialysate collection. In vivo probe recoveries were estimated by retrodialysis using a calibrator method, with ciprofloxacin (CIP) as the calibrator. LVX and CIP were analyzed in dialysates by high-performance liquid chromatography. The steady-state tissue-to-blood unbound-drug concentration ratios were 1.00 +/- 0.15 in muscle tissues and 1.06 +/- 0.40 in lungs, suggesting passive distribution of LVX in tissue. Although providing no information on rate of distribution, microdialysis investigations following drug infusion at steady state appear to be an interesting approach for characterization of antibiotic distribution in rat lungs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591278      PMCID: PMC2533480          DOI: 10.1128/AAC.00242-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Dose ranging pharmacokinetics and brain distribution of norfloxacin using microdialysis in rats.

Authors:  Sandrine Marchand; Marylore Chenel; Isabelle Lamarche; Claudine Pariat; William Couet
Journal:  J Pharm Sci       Date:  2003-12       Impact factor: 3.534

2.  GF120918, a P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats.

Authors:  Jeffrey E Edwards; Kenneth R Brouwer; Patrick J McNamara
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Interstitial tissue concentrations of cefpodoxime.

Authors:  Ping Liu; Markus Müller; Maria Grant; Alistair I Webb; Bernd Obermann; Hartmut Derendorf
Journal:  J Antimicrob Chemother       Date:  2002-07       Impact factor: 5.790

Review 4.  Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review).

Authors:  Markus Zeitlinger; Markus Müller; Christian Joukhadar
Journal:  AAPS J       Date:  2005-10-22       Impact factor: 4.009

5.  In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.

Authors:  Doris Hutschala; Keso Skhirtladze; Andreas Zuckermann; Wilfried Wisser; Peter Jaksch; Bernhard Xaver Mayer-Helm; Heinz Burgmann; Ernst Wolner; Markus Müller; Edda M Tschernko
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.

Authors:  John E Conte; Jeffrey A Golden; Mary Grace Kelley; Elisabeth Zurlinden
Journal:  Int J Antimicrob Agents       Date:  2005-11-08       Impact factor: 5.283

Review 7.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Authors:  Elaine M Leslie; Roger G Deeley; Susan P C Cole
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

8.  Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats.

Authors:  Sandrine Marchand; Claire Dahyot; Isabelle Lamarche; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

9.  Tissue pharmacokinetics of levofloxacin in human soft tissue infections.

Authors:  Romuald Bellmann; Gerald Kuchling; Pejman Dehghanyar; Markus Zeitlinger; Erich Minar; Bernhard X Mayer; Markus Müller; Christian Joukhadar
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

10.  Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis.

Authors:  L Granero; M Santiago; J Cano; A Machado; J E Peris
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

View more
  5 in total

1.  Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.

Authors:  Estevan Sonego Zimmermann; João Victor Laureano; Camila Neris Dos Santos; Stephan Schmidt; Chakradhar V Lagishetty; Whocely Victor de Castro; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

2.  Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.

Authors:  Aline Vidal Lacerda Gontijo; Julien Brillault; Nicolas Grégoire; Isabelle Lamarche; Patrice Gobin; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 3.  Innovative preclinical models for pulmonary drug delivery research.

Authors:  Stephan Ehrmann; Otmar Schmid; Chantal Darquenne; Barbara Rothen-Rutishauser; Josue Sznitman; Lin Yang; Hana Barosova; Laurent Vecellio; Jolyon Mitchell; Nathalie Heuze-Vourc'h
Journal:  Expert Opin Drug Deliv       Date:  2020-02-23       Impact factor: 6.648

4.  Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Authors:  Felipe K Hurtado; Benjamin Weber; Hartmut Derendorf; Guenther Hochhaus; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

5.  P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.

Authors:  Julien Brillault; Whocely Victor De Castro; Thomas Harnois; Alain Kitzis; Jean-Christophe Olivier; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.